Benefits and Risks of Early Antiretroviral Treatment Initiation and 6-Months Isoniazid Prophylaxis in HIV-Infected West African Adults : a Randomized Factorial Trial (ANRS 12136 TEMPRANO).
Phase of Trial: Phase III
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Efavirenz (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Isoniazid; Lopinavir/ritonavir
- Indications HIV-1 infections; HIV-2 infections; Tuberculosis
- Focus Therapeutic Use
- Acronyms TEMPRANO
- 07 Jun 2017 Biomarkers information updated
- 02 Jun 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 19 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History